Correlation Between Microsoft and Tema Oncology
Can any of the company-specific risk be diversified away by investing in both Microsoft and Tema Oncology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Microsoft and Tema Oncology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Microsoft and Tema Oncology ETF, you can compare the effects of market volatilities on Microsoft and Tema Oncology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Microsoft with a short position of Tema Oncology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Microsoft and Tema Oncology.
Diversification Opportunities for Microsoft and Tema Oncology
0.03 | Correlation Coefficient |
Significant diversification
The 3 months correlation between Microsoft and Tema is 0.03. Overlapping area represents the amount of risk that can be diversified away by holding Microsoft and Tema Oncology ETF in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Tema Oncology ETF and Microsoft is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Microsoft are associated (or correlated) with Tema Oncology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Tema Oncology ETF has no effect on the direction of Microsoft i.e., Microsoft and Tema Oncology go up and down completely randomly.
Pair Corralation between Microsoft and Tema Oncology
Given the investment horizon of 90 days Microsoft is expected to generate 16.67 times less return on investment than Tema Oncology. But when comparing it to its historical volatility, Microsoft is 26.57 times less risky than Tema Oncology. It trades about 0.08 of its potential returns per unit of risk. Tema Oncology ETF is currently generating about 0.05 of returns per unit of risk over similar time horizon. If you would invest 352.00 in Tema Oncology ETF on November 9, 2024 and sell it today you would earn a total of 2,203 from holding Tema Oncology ETF or generate 625.85% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 75.66% |
| Values | Daily Returns |
Microsoft vs. Tema Oncology ETF
Performance |
| Timeline |
| Microsoft |
| Tema Oncology ETF |
Microsoft and Tema Oncology Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Microsoft and Tema Oncology
The main advantage of trading using opposite Microsoft and Tema Oncology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Microsoft position performs unexpectedly, Tema Oncology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Tema Oncology will offset losses from the drop in Tema Oncology's long position.| Microsoft vs. Palo Alto Networks | Microsoft vs. Uipath Inc | Microsoft vs. Adobe Systems Incorporated | Microsoft vs. Crowdstrike Holdings |
| Tema Oncology vs. Freedom Day Dividend | Tema Oncology vs. Franklin Templeton ETF | Tema Oncology vs. iShares MSCI China | Tema Oncology vs. Tidal Trust II |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.
Other Complementary Tools
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Stocks Directory Find actively traded stocks across global markets | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities |